Detalhe da pesquisa
1.
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial.
Breast Cancer Res Treat
; 185(3): 741-758, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179154
2.
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
Breast Cancer Res
; 21(1): 97, 2019 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455425
3.
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).
Breast Cancer Res
; 18(1): 3, 2016 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26738606
4.
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.
Nat Commun
; 11(1): 3083, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32576828
5.
Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 2(8): 1030-7, 2016 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27348762
6.
Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
Mol Cancer Ther
; 14(3): 821-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25552367
7.
Effects of cyclosporine a on single-dose pharmacokinetics of intravenous itraconazole in patients with hematologic malignancies.
Ther Drug Monit
; 30(3): 301-5, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18520601